[ad_1]
The company made its comment on Thursday in response to a debate in parliament about the company’s role in making vaccines.
“Thermo Fisher Scientific is proud to participate in more than 200 global projects to prevent Covid-19 infection, helping customers develop and manufacture Covid-19 vaccines, and develop new therapies and treatments,” the report says.
“The Vilnius division does not produce any vaccine, but we supply customers with life science reagents that can eventually be used as components in vaccine development and development,” the company said.
On Thursday, during an hour of government in the Seimas, the opposition parliamentarian Aušrinė Armonaitė asked the Minister of Health about the alleged production of a vaccine in Lithuania for the US market.
“Do you know that in Lithuania Thermo Fisher Scientific manufactures the Covid vaccine for the US market and even, as I understand it, creates an extension for Moderna and Pfizer vaccines? Are they negotiating with them so that we can buy the vaccine, which is produced here in Lithuania, so we can get it faster? ”asked A. Armonait Preg to Minister of Health Aurelijus Verygos.
Responding to a question, the Minister of Health, Aurelijus Veryga, emphasized that the member states of the European Union that have joined the joint procurement mechanism cannot negotiate with the producers separately.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
